Constructing probability density function of net-proton multiplicity distributions using Pearson curve method

The probability density functions of net-proton multiplicity distributions are constructed from the Beam Energy Scan results of the STAR experiment using the Pearson curve method for two different transverse momentum windows. The $6^{th}$ and $8^{th}$ order cumulants of net-proton multiplicity distributions are estimated from the constructed probability density functions. The beam energy dependence of $C_{6}/C_{2}$ and $C_{8}/C_{2}$ are found to be sensitive to the acceptance window. This method provides a unique opportunity to study the O(4) criticality near the chiral crossover transition and estimating the higher-order cumulants. In general, it is useful to determine the probability density function uniquely of a frequency data if the first four cumulants are known.Comment: 8 pages, 6 figures, text modifie

FDTD Analysis of Electromagnetic Wave Propagation in an Inhomogeneous Ionosphere under Arbitrary-Direction Geomagnetic Field

The finite-difference time-domain (FDTD) model was developed to analyze electromagnetic (EM) wave propagation in an inhomogeneous ionosphere. The EM analysis of ionosphere is complicated, owing to various propagation environments that are significantly influenced by plasma frequency, cyclotron frequency, and collision frequency. Based on the simple auxiliary differential equation (ADE) technique, we present an accurate FDTD algorithm suitable for the EM analysis of complex phenomena in the ionosphere under arbitrary-direction geomagnetic field. Numerical examples are used to validate our FDTD model in terms of the reflection coefficient of a single magnetized plasma slab. Based on the FDTD formulation developed here, we investigate EM wave propagation characteristics in the ionosphere using realistic ionospheric data for South Korea

Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein

BACKGROUND: Heptaplatin is a new platinum derivative with anticancer activity against various cancer cell lines, including cisplatin-resistant cancer cell lines (Cancer Chemother Pharmacol 1995; 35: 441). METHODS: Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines has been investigated in connection with metallothionein (MT). Cytotoxicity was determined by an MTT assay. MT mRNA, was determined by RT-PCR assay. Transfection study was carried out to examine the function of MT. RESULTS: Of various gastric cancer cell lines, SNU-638 and SNU-601 showed the highest and lowest levels of MT mRNA, respectively, showing 80-fold difference. The IC(50 )values of SNU-638 to cisplatin, carboplatin and heptaplatin were 11.2-fold, 5.1-fold and 2.0-fold greater than those of SNU-601, respectively. Heptaplatin was more effective against cisplatin-resistant and MT-transfected gastric cancer sublines than cisplatin or carboplatin was. In addition, heptaplatin attenuated cadmium, but not zinc, induction of MT. CONCLUSION: These results indicate that molecular mechanisms of heptaplatin effective against cisplatin-resistant gastric cancer sublines is at least in part due to the less involvement of MT in heptaplatin resistance as well as its attenuation of MT induction

Duodenal Duplication Cysts of Ampulla of Vater Containing Stone

Duodenal duplication cysts are rare congenital malformations. Most symptomatic cases are diagnosed in children and usually present with obstructive findings or bleeding symptoms. Treatment traditionally involves surgical resection, which can be often difficult because of the close proximity of the cysts to the papilla and bilopancreatic confluence. Endoscopic therapy has been used as an alternative to open surgery in a few selected cases. We report a case with a duodenal duplication cyst containing a brown pigmented stone within the cystic lumen. He was visited because of sudden right upper quadrant abdominal pain. An abdominal computed tomography revealed the presence of a cyst with a stone, which was finally removed by endoscopic resection

Effect of Chongkukjang on histamine-induced skin wheal response: A randomized, double-blind, placebo-controlled trial

AbstractBackgroundStudies in animals have demonstrated the antiallergenic properties of Chongkukjang (CKJ), a traditional Korean food made by fermentation of soybean with Bacillus subtilis. CKJ might therefore be used as an ingredient in a functional food designed to suppress allergies. The purpose of this study was to investigate the effect of CKJ on histamine-induced skin wheal response in healthy participants.MethodsA randomized, double-blind, placebo-controlled trial was conducted. Sixty participants (48 women and 12 men) were randomly assigned to one of two groups: One group received 35 g CKJ daily for 12 weeks, and the other received a placebo at the same dosing frequency. A skin prick test with histamine (10 mg/mL) was conducted on the ventral forearm 10 cm from the elbow, and assessed 15 minutes later. Outcomes included measurement of efficacy [skin wheal response, immunoglobulin E (IgE), histamine, interferon-gamma, interleukin-4, eosinophil, and eosinophil cationic protein (ECP)], and safety (adverse events, laboratory test results, electrocardiogram, anthropometric values, and vital signs).ResultsFifty-five participants (28 in the CKJ group and 27 in the placebo group) completed the study. After 12 weeks of supplementation, participants in the CKJ group showed a significant reduction in histamine-induced skin wheal areas compared with placebo group (p < 0.05). At 12 weeks, the CKJ group showed a significant improvement in percentage change from baseline in histamine-induced wheal area, compared with the placebo group (p < 0.05). CKJ did not influence blood levels of IgE, histamine, interferon-gamma, interleukin-4, eosinophil, or ECP.ConclusionOral administration of CKJ for 12 weeks resulted in a reduction of the skin wheal response to histamine, with no apparent adverse effects. Trial registration: ClinicalTrials.gov: NCT01402141